Wednesday, May 07, 2025

 

Rare hunting dogs’ unique noses may offer clue to cause of cleft lip and palate in humans



KTH, Royal Institute of Technology
Turkish Pointer 

image: 

A gene mutation linked to the unique noses of Turkish Pointers – or Catalburun – has been identified.

view more 

Credit: Reuben M. Buckley, et al





It’s not entirely understood why some children are born with orofacial clefts, such as cleft lip or palate. But a new study suggests a genetic clue may be found in a rare breed of hunting dog.

An international research team reports that it identified the genetic origins of the forked nose that distinguishes Turkish Pointers – or Catalburun – a breed that have been prized for their supposed superior sense of smell. Publishing in the scientific journal Genome Research, the researchers traced the dogs’ forked, or bifid, nose to a mutation of the gene PDFGRA.

Peter Savolainen, a canine genealogy authority at Stockholm's KTH Royal Institute of Technology, says the study raises the possibility that there may be a connection between the mutation of PDFGRA and cases of human orofacial clefts.

One indication is in the role PDFGRA was previously found to play in embryonic development of mice. PDFGRA is essential for connecting the halves of the mouth and nose during embryonic development, the study stated.

“This indicates that the gene might be involved in some cases of human orofacial clefts,” Savolainen says. “While there are several genetic and environmental reasons behind orofacial clefts in humans, this study offers a clue to another factor.”

A mutated variant of PDFGRA was also found to be behind unexpected forked-nose deformities in other breeds of dog. The researchers also found two mutations in another gene, LCORL, which code for large breeds and small breeds, respectively.

The work was a collaboration between KTH Royal Institute of Technology, the U.S. National Human Genome Research Institute; University of Ankara; Afyon Kocatepe University and University of Selcuk in Turkey; Utrecht University in the Netherlands; University of Helsinki and Folkhälsan Research Center in Finland; Cornell University in Ithaca, New York; and Embark Veterinary in Boston, Massachusetts.

Savolainen says the research demonstrates how studying the smaller gene pool of bred dogs provides valuable genomic insights for medical science. “Studying the very inbred dog breeds is an excellent tool for finding the genetic reason for many morphologic traits and diseases in humans,” he says.

“In humans there is just too much genetic variation, making it hard to identify exactly which genetic mutation causes a specific disease,” he says.

  

A mixed breed dog with a forked nose. 

An international research team reports that it identified the genetic origins of the forked nose that distinguishes Turkish Pointers – or Catalburun – a breed that have been prized for their supposed superior sense of smell. Pictured, a mixed breed dog with a bifid nose (left) and a Turkish pointer (right). 

Credit

Reuben M. Buckley, et al

 

Professor Xu Zhangrun receives Human Rights Award


Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) honors Chinese legal scholar



Friedrich-Alexander-Universität Erlangen-Nürnberg





Xu Zhangrun, formerly a professor at Tsinghua University in Beijing, is this year’s recipient of the Human Rights Award from Friedrich-Alexander Universität Erlangen-Nürnberg (FAU). The award has been presented every two years since 2022 to international researchers who have made significant contributions to human rights. For many years, Xu Zhangrun has advocated for democracy, academic freedom, and freedom of expression in his scholarly work, and has opposed autocratic injustice in China. FAU Vice President Prof. Dr. Andreas Hirsch symbolically placed the award on the empty chair of the laureate, who lives under strict surveillance in Beijing and is not allowed to leave the country.

“Throughout his academic career, Professor Xu has taught and researched aspects of constitutional law and constitutionalism, human rights and the rule of law, as well as Chinese and Western intellectual history,” praised Prof. Dr. Eva Pils, the laudator, Humboldt Professor, and board member of the Center for Human Rights Erlangen-Nürnberg (CHREN) at FAU. “His works are characterized by a distinctive literary style that draws on historical comparisons and does not shy away from robust and direct political criticism of the system and individual leaders. For this, he has received much admiration.” He has been a role model for other scholars and students in China and beyond, she continued. “His publications in recent years, especially since 2018, have led to massive persecution precisely because they had a significant impact on public discourse in Chinese society up to that point,” Pils noted.

Prof. Dr. Heiner Bielefeldt, Senior Professor for Human Rights at the Institute of Political Science at FAU and former UN Special Rapporteur on Freedom of Religion or Belief, also emphasized the importance of Xu Zhangrun’s work for human rights: “Even as we honor Xu Zhangrun with the Human Rights Award, it is us who are honored to benefit from his work: His courage can be an inspiration for us.”

Prof. Dr. Andreas Hirsch, Vice President People at FAU, symbolically placed the award on the empty chair: Xu Zhangrun lives under house arrest in Beijing and could not personally accept the award. “We would have liked to honor this significant scholar in person and foster academic exchange,” said Hirsch. “I thank Professor Xu for his commitment and place this year’s Human Rights Award on this empty chair in the hope that Professor Xu may soon be able to collect it.”

About the Laureate Xu Zhangrun

Professor Xu Zhangrun, born in 1962, was a professor of legal philosophy and constitutional law at Tsinghua University in Beijing until 2018. In 2002, he received the university’s highest research award. 
Xu Zhangrun holds a BA from the Southwestern University of Politics and Law, a Master’s degree from the China University of Political Science and Law, and a PhD in legal philosophy and legal history from the University of Melbourne (awarded in 2000).

After returning from Australia to Beijing, he took a position as an associate professor at Tsinghua University and rose through the ranks, also taking on the leadership of the Tsinghua University Center for Rule of Law and Human Rights Research. He was also a member of the Unirule Institute, a liberal think tank for economics and politics based in Beijing, which was closed in July 2018.

He currently lives on the outskirts of Beijing under strict surveillance, which lacks any legal basis. He is not allowed to leave the city without permission. Although he was officially retired, he receives neither a pension nor social assistance. He was also evicted from his former university residence and is completely isolated due to the intimidation of colleagues and students.

Some of Professor Xu’s recent works are available in translation by Professor Geremie Barmé on the China Heritage website, including his essay “Imminent fears, immediate hopes,” which was published online in 2018, attracted significant attention, and led to increased persecution, as well as his essay “Viral alarm: When fury overcomes fear,” published online in 2020.

His current work, “Against morality and reason: Outlines of a theory of legal injustice,” is currently being translated and published in French by Gallimard, after a Chinese publication project was halted due to censorship.

 

Paper sensors and smartphone app monitor personal smoke exposure



Washington State University




An inexpensive paper sensor along with a smartphone-based reader developed by a Washington State University-led team can rapidly provide information on a person’s personal smoke exposure during wildfire season.

The sensor can provide valuable information for firefighters and others to clarify just how much harmful pollution they might inhale during smoky conditions. The researchers, including from University of Washington and University of Georgia, report on their work in the journal, ACS Applied Materials and Interfaces.

The paper biosensor uses tiny, flower-like particles of palladium and platinum to detect and amplify the signal from wildfire smoke biomarkers in urine. To make the system field-ready, the team also developed a custom 3D-printed smartphone reader and app, allowing users to rapidly scan and quantify their exposure on-site.

“Our goal is to quickly identify the exposure onsite in real time and report it with a smartphone reader, so agencies can quickly identify the exposure level and location and make decisions for a hazard prevention strategy,” said Annie Du, a research professor in WSU’s School of Mechanical and Materials Engineering who is leading the project.

With the increasing number and size of wildfires in recent years, researchers would like better information on people’s personal smoke exposure to understand and mitigate its health impacts more effectively. Human exposure to wood smoke is linked to numerous health issues, including respiratory disease, cardiovascular disease, and lung cancer.

Currently, estimates of a person’s smoke exposure level are not exact. Agencies determine how much smoke a person may be exposed to based on computer models that use regional meteorology, satellite data, air quality sensors in the region, or even personal perceptions of smoke levels. Those methods sometimes miss the big variations in smoke that can happen in a small area. They also don’t get a person’s specific exposure levels to chemicals or how a person might variably metabolize and process pollutants in his or her body.

Furthermore, exposure to pollutants from wildfires could have impacts on people – even if they don’t have a lot of symptoms.

“You’re exposed to smoke when you breathe in the polluted air, but your body changes that to a metabolite and introduces changes to your DNA,” said Du, who is also in the College of Pharmacy and Pharmaceutical Sciences. “That’s why we are focused on early detection -- We want to catch biological changes before clinical symptoms appear.”

There are blood tests to measure smoke exposure, but they’re cumbersome and expensive, requiring that samples be sent to a laboratory for analysis. When fires are in remote areas, getting information on a person’s exposure is even more difficult.

With the test strips, the researchers were able to measure tiny amounts of metabolites from the pollutant benzene.  Their biosensor device is low-cost and very sensitive to the signal of the benzene metabolites.

Unlike a COVID test strip, which only determines whether or not a person has COVID, their sensor can quantify the amount of harmful chemicals someone has been exposed to. The 3D-printed sensor can be connected to a smartphone, so that using a phone’s location data, researchers can determine exactly where smoke levels are most hazardous and identify the chemicals present in different neighborhoods.

The researchers have tested the strips in a lab setting. They will now begin testing the strips with firefighters during the wildfire season and comparing them to standard lab tests. While they will initially test with wildland firefighters, they are working with WSU’s Office of Commercialization and plan to adapt and expand the technology to other vulnerable populations in the future. The work was funded by the Centers for Disease Control and Prevention.

 

Smart lactation pads can monitor safety of breast milk in real time



Cell Press
Lactation pad 

image: 

The lactation pad is removable for sanitary disposal and could be used for further testing.

view more 

Credit: Mousavi et al., Device




Scientists at the University of Southern California (USC) have developed a lactation pad equipped with sensing technology that allows parents of newborns to monitor breast milk in real time. Publishing in the Cell Press journal Device on May 7, their work shows that the device is capable of ensuring that breast milk contains safe levels of the painkiller acetaminophen, which is often prescribed after childbirth and can be transferred to breastfeeding infants. 

“Our device represents a major innovation,” says first author Maral Mousavi, an assistant professor of biomedical engineering at USC. “It is the first wearable tool for direct biochemical analysis in breast milk and the first lactation pad embedded with real-time sensing technology. This technology has the potential to empower lactating individuals with actionable health insights, supporting both maternal and infant health in ways that have never before been possible.” 

To make the device, the researchers installed electrodes and tiny channels into a lactation pad—an apparatus that nursing parents often wear throughout the day to protect their clothes from leaking breast milk. The smart lactation pad functions by measuring samples of the milk for acetaminophen as lactating parents go about their regular routines without requiring additional effort from the parent. 

Since the smart pad continuously monitors levels of acetaminophen in the milk throughout the day, it also offers a tool for scientists to better understand how drugs are transferred into breast milk, says Mousavi. 

“While it is generally safe at recommended doses, acetaminophen overexposure is a leading cause of acute liver failure in children,” she says. “It remains the most common reason for liver transplants related to drug toxicity.” 

The researchers were inspired to build the lactation pad after a graduate student in their research group gave birth and was prescribed acetaminophen to manage her postpartum pain. Despite the importance of breast milk as a source of nutrition for infants and its ability to help their fragile immune systems develop, the team found that few technologies existed to monitor its safety in real time. While a few companies offer mail-in services, these services involve collecting samples in specialized kits that can be costly and waiting days or weeks for results. 

“Given the risks and the critical decision-making parents face around breastfeeding and medication use, we wanted to create a tool that empowers them with real-time, personalized information rather than leaving them to rely on generalized drug-safety charts or delayed lab testing,” says Mousavi.  

The team hopes that the smart lactation pad can help parents make more informed decisions about breastfeeding after taking medications, such as optimizing the “pump and dump” strategy or discarding breast milk when drug levels are the highest.    

In addition to painkillers, the authors note that new mothers are also commonly prescribed antibiotics or antifungals, and although these medications are generally considered safe to take while breastfeeding, they aren’t always benign.  

While the version of the smart pad described in this study was developed to measure acetaminophen, Mousavi says that it can be adapted to detect other drugs and biomarkers for assessing health. For example, Mousavi and colleagues recently demonstrated another lactation pad with an embedded sensor designed to monitor glucose levels in breast milk—a function which she says could help parents manage their nutrition and address conditions such as gestational diabetes.  

Currently, the device is only able to measure milk produced from natural leakage, meaning its applications may be limited when little leakage occurs. The pads are also disposable, so a new lactation pad is required for each new test. The researchers are currently working to develop a version of the device that analyzes pumped milk to offer a more accessible and convenient testing option for parents. 

### 

Device, Mohamed et al.,“Safer breastfeeding with a wearable sensor for maternal acetaminophen transfer through breast milk.” https://www.cell.com/device/fulltext/S2666-9986(25)00087-0

Device (@Device_CP), is a physical science journal from Cell Press along with Chem, Joule, and Matter. Device aims to be the breakthrough journal to support device- and application-oriented research from all disciplines, including applied physics, applied materials, nanotechnology, robotics, energy research, chemistry, and biotechnology under a single title that focuses on the integration of these diverse disciplines in the creation of the cutting-edge technology of tomorrow. Visit http://www.cell.com/device/home. To receive Cell Press media alerts, contact press@cell.com

 

Specialized face mask can detect kidney disease with just your breath



American Chemical Society
Specialized face mask can detect kidney disease with just your breath 

image: 

Embedded between the fabric layers of this FFP2-style face mask is a specialized gas sensor that could help diagnose chronic kidney disease from a person’s breath.

view more 

Credit: Adapted from ACS Sensors 2025, DOI: 10.1021/acssensors.4c03227




Surgical face masks help prevent the spread of airborne pathogens and therefore were ubiquitous during the COVID-19 pandemic. Now, a modified mask could also protect a wearer by detecting health conditions, including chronic kidney disease. Researchers reporting in ACS Sensors incorporated a specialized breath sensor within the fabric of a face mask to detect metabolites associated with the disease. In initial tests, the sensor correctly identified people with the condition most of the time.

Kidneys remove waste products made by the body’s metabolic processes. But in the case of chronic kidney disease (CKD), these organs have become damaged and lose function over time, which can have wide-ranging implications on a person’s health. The U.S. Centers for Disease Control and Prevention estimates that 35 million Americans have CKD, and many more could have the disease without knowing it, possibly at an early stage. Currently, medical professionals diagnose the condition by measuring metabolites in blood or urine, but low-cost, low-tech systems, like the ones made from specialized candies, could make the process easier.

Chemical breath sensors are another diagnostic tool currently being explored because people with CKD exhale elevated levels of ammonia — a chemical associated with the condition. However, ammonia is also associated with other health conditions. Corrado Di Natale and colleagues wanted to create a specific sensor that simultaneously detects ammonia and other CKD-related metabolites.

For ease of use, they incorporated the sensor into a familiar form: a surgical face mask. To create the breath sensor, the team first coated silver electrodes with a conductive polymer that is commonly used in chemical sensors. The polymer was modified with porphyrins — molecules sensitive to volatile compounds — to boost the sensitivity. The coated electrodes were placed between the layers of a disposable medical face mask, and wires connected the device to an electronic readout. When select gases interacted with this specialized polymer, it caused a measurable change of electrical resistance. These initial experiments in air confirmed the high sensitivity of the sensor for CKD-related metabolites, including ammonia, ethanol, propanol and acetone.

Then the specialized face masks were tested on 100 individuals. About half of the participants had a CKD diagnosis, and the other half (the control group) did not. The sensors detected several compounds in the participants’ breath, and statistical analysis of the data revealed a clear pattern distinguishing the participants with CKD from the control group. The team’s sensor correctly identified when a patient had CKD 84% of the time (true positive) and that a patient did not have CKD 88% of the time (true negative). In addition, the results suggest that the sensor data can be used to estimate the stage of CKD, which could be highly valuable in the diagnostic process.

The researchers say that these findings present the potential for straightforward, non-invasive and cost-effective monitoring of CKD patients.

“The implementation of this technology is expected to enhance the management of CKD patients by facilitating the timely identification of changes in disease progression,” say Sergio Bernardini and Annalisa Noce, coauthors of the study.

The authors acknowledge funding from the European Union’s NextGenerationEU project.

The paper’s abstract will be available on May 7 at 8 a.m. Eastern time here: http://pubs.acs.org/doi/abs/10.1021/acssensors.4c03227  

###

The American Chemical Society (ACS) is a nonprofit organization chartered by the U.S. Congress. ACS’ mission is to advance the broader chemistry enterprise and its practitioners for the benefit of Earth and all its people. The Society is a global leader in promoting excellence in science education and providing access to chemistry-related information and research through its multiple research solutions, peer-reviewed journals, scientific conferences, e-books and weekly news periodical Chemical & Engineering News. ACS journals are among the most cited, most trusted and most read within the scientific literature; however, ACS itself does not conduct chemical research. As a leader in scientific information solutions, its CAS division partners with global innovators to accelerate breakthroughs by curating, connecting and analyzing the world’s scientific knowledge. ACS’ main offices are in Washington, D.C., and Columbus, Ohio.

Registered journalists can subscribe to the ACS journalist news portal on EurekAlert! to access embargoed and public science press releases. For media inquiries, contact newsroom@acs.org.

Note: ACS does not conduct research but publishes and publicizes peer-reviewed scientific studies.

Follow us: Facebook | LinkedIn | Instagram

 

Chronic illnesses such as asthma and allergies have psychological impacts



May issue of Annals of Allergy, Asthma and Immunology explores mental health concerns




American College of Allergy, Asthma, and Immunology




ARLINGTON HEIGHTS, Ill. (May 7, 2025) – People who have struggled with asthma or allergies for years understand the psychological toll of these conditions. The May issue of Annals of Allergy, Asthma and Immunology (Annals), the scientific journal of the American College of Allergy, Asthma and Immunology, explores the mental health burden these conditions can exact.

“The diseases we treat in allergy/immunology are primarily chronic illnesses and they often have a psychological impact on those who suffer from them,” says allergist Mitchell Grayson, MD, editor in chief of Annals. “Sometimes, as doctors, we focus on the diagnosis and treatment of the disease but don’t realize the suffering that the patient is undergoing. Fear and anxiety can be major components of allergic diseases and can greatly interfere with successful treatment of the underlying disease. In this issue we explore the mental health impacts of atopic dermatitis, food allergy, and asthma. We not only describe the mental health impacts on patients, but also (and more importantly) explore ways in which clinicians can mitigate these effects leading to better care for their patients.”

Below are summaries from the abstracts of three of the mental health articles featured in the May issue of Annals:

Title: Depression and Anxiety in Patients with Atopic Dermatitis: Recognizing and Addressing Mental Health Burden

“The psychosocial burden of atopic dermatitis (AD) is extensive, stemming from intense itch, sleep disturbance, unpredictable flares, social stigma, treatment burden, lifestyle restrictions and missed activities…Although depression and anxiety are known comorbidities of AD, the mental health burden of AD often goes unaddressed, which may further a sense of isolation for patients and families. Given the strong association between symptom severity and increased mental health burden, optimizing AD treatment and reducing itch are critical. Health care professionals can support patients with AD and their caregivers by encouraging open conversations about mental health, addressing common areas of condition-related stress, screening for depression and anxiety, and facilitating referrals to mental health professionals for further assessment and evidence-based care…Further research is needed to  evaluate psychological interventions for pediatric patients with AD and for patients with clinical diagnoses of depression and anxiety to better guide shared decision-making around support for these patients.”

Title: Managing Childhood Asthma with an Eye Toward Environmental, Social and Behavioral Features

“Discussions around asthma management tend to focus on the therapeutic aspects… However, there are many other components of asthma management that are now receiving increased attention as we seek to make right on health disparities and strive towards health equity…On the other hand, we know very little about what we can do to control the other inflammatory features that contribute to asthma. Factors, such as environmental exposures, social determinants of health and risk-taking behaviors may be at the root of asthma persistence, progression and co-morbidities. We continue to learn about methods to identify these issues and draw them into a shared decision-making approach to dialogue with patients and their caregivers. In this review, we provide information and available tools to address these non-pharmacologic aspects of asthma management.”

Title: Want to Help Your Patients with Food Allergy Anxiety? Do Proximity Challenges!

“In their landmark paper published nearly a decade ago, Dinakar and colleagues recommended that food allergists incorporate proximity food challenges into clinical practice to improve patient knowledge and anxiety. Such challenges are akin to the exposure tasks routinely employed in cognitive-behavioral therapy (CBT), the first-line psychosocial intervention for anxiety disorders. Exposure is a therapy technique where a person…directly, strategically, and repeatedly confronts their feared object, situation, or activity in real life... Following a summary of the history and evidence-base for exposure in both the psychiatric and food allergy literature, we review several considerations related to conducting in-office proximity challenges. Topics include assessment of anxiety and medically unnecessary avoidance, choosing appropriate, individualized proximity challenges based on patient presentation, and practical considerations in carrying out in-office proximity challenges to maximize benefit to anxious patients.”

Dr. Grayson noted on the topic of theme issues, “Theme issues allow Annals the opportunity to highlight a specific issue, disease, or concept in a way where the reader gets a more concentrated exposure. This makes for a better reader experience and allows the reader to better focus on the specific topic of the issue. Having themes also allows readers to pull specific issues that contain the information they are interested in when they need that information. In addition, Annals has online article collections (at www.annallergy.org)  where readers can find groupings of articles (from multiple theme issues).”

About ACAAI

The ACAAI is the premier professional medical organization of more than 6,000 allergists-immunologists and allied health professionals, headquartered in Arlington Heights, Ill. The College fosters a culture of collaboration and congeniality in which its members work together and with others toward the common goals of patient care, education, advocacy, and research. ACAAI allergists are board-certified physicians trained to diagnose allergies and asthma, administer immunotherapy, and provide patients with the best treatment outcomes. For more information and to find relief, visit AllergyandAsthmaRelief.org. Join us on FacebookPinterestInstagramTwitter/X and Threads.